Sellas Life Sciences Group Inc (SLS)
Financing Cash Flow
$141.47M
TTM · Period ending: · USD
SLS Financing Cash Flow
Latest reported$141.47Mperiod ending
Latest reported$141.47Mperiod ending
SLS TTM Cash from Financing ($17.83M → $141.47M)
TTM financing cash flow
High-resolution chart · PNG
SLS financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 141,469,000 | |
| 106,865,000 | |
| 86,296,000 | |
| 53,910,000 | |
| 47,509,000 | |
| 43,693,000 | |
| 46,758,000 | |
| 50,136,000 | |
| 30,500,000 | |
| 30,057,000 | |
| 22,315,000 | |
| 19,858,000 | |
| 19,911,000 | |
| 42,936,000 | |
| 24,079,000 | |
| 23,200,000 | |
| 25,335,000 | |
| 9,121,000 | |
| 12,074,000 | |
| 35,699,000 | |
| 41,949,000 | |
| 35,142,000 | |
| 38,442,000 | |
| 17,086,000 | |
| 8,783,000 | |
| 23,639,000 | |
| 19,569,000 | |
| 17,174,000 | |
| 31,237,000 | |
| 20,614,000 | |
| 23,123,000 | |
| 7,664,000 | |
| -5,498,000 | |
| -4,051,000 | |
| 11,189,000 | |
| 28,293,000 | |
| 44,335,000 | |
| 35,052,000 | |
| 34,324,000 | |
| 31,746,000 | |
| 13,855,000 | |
| 21,812,000 | |
| 43,845,000 | |
| 54,709,000 | |
| 55,134,000 | |
| 50,824,000 | |
| 24,260,000 | |
| 22,067,000 | |
| 60,141,000 | |
| 70,552,000 | |
| 55,924,000 | |
| 70,814,000 | |
| 33,434,000 | |
| 40,363,000 | |
| 42,424,000 | |
| 19,882,000 | |
| 20,695,000 | |
| 14,058,000 | |
| 19,196,000 | |
| 19,161,000 | |
| 17,973,000 | |
| 7,233,000 | |
| 11,570,000 | |
| 11,579,000 | |
| 19,300,000 | |
| 19,312,000 | |
| 7,680,000 | |
| 7,717,000 | |
| -9,000 | |
| 7,918,000 | |
| 7,922,000 | |
| 7,697,000 | |
| 9,059,000 | |
| 16,768,000 | |
| 17,833,000 | |
| 18,323,000 |